Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Analyst gives Pfizer advanced lung cancer drug 80 percent chance of receiving FDA approval
Analyst gives Pfizer advanced lung cancer drug 80 percent chance of receiving FDA approval
Analyst gives Pfizer advanced lung cancer drug 80 percent chance of receiving FDA approval
Submitted by
admin
on June 16, 2011 - 12:10pm
Source:
Yahoo/AP
News Tags:
FDA
lung cancer
crizotinib
Headline:
Analyst gives Pfizer advanced lung cancer drug 80 percent chance of receiving FDA approval
Do Not Allow Advertisers to Use My Personal information
